Compare Ecopetrol SA (EC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Moderna, Inc. — how do they compare? Ecopetrol SA trades at $16.93 (market cap $33.69B), while Moderna, Inc. trades at $61.4 (market cap $24.18B). The key difference: Ecopetrol SA is the larger of the two by market cap, and Ecopetrol SA pays a 3.82% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| EC | MRNA | |
|---|---|---|
Market Cap | $33.69B | $24.18B |
Sector | Energy | Health |
52-Week High | $17.40 | $81.80 |
52-Week Low | $8.56 | $22.36 |
Enterprise Value | $63.86B | $20.33B |
Dividend Yield | 3.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $17.05, up 1.61% with a bullish technical signal from moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing declining revenue trends from $119.69T in 2025 to $116.95T projected for 2026. Recent developments include a cybersecurity incident in July 2026 and ongoing acquisition activities in Brazil's energy sector through Brava Energia.
The stock presents a value opportunity with attractive valuation ratios (P/E 11.11, P/S 0.97) but faces headwinds from declining revenue and profit margins. Analyst consensus is cautious with a $15 price target below current levels, while institutional sentiment shows mixed ratings amid operational challenges and cybersecurity risks.
Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.
Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
